RAPID DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13: PERFORMANCE COMPARISON WITH ELISA

被引：0
|
作者：
Fiorino, Gionata
Ametzazurra, Amagoia
Nagore, Daniel
Hernandez, Alba Maria
Torres, Nerea
Radice, Simona
Gilardi, Daniela
Correale, Carmen
Allocca, Mariangela
Furfaro, Federica
Alfieri, Marina F.
Pascual, Javier
Recalde, Xabier
Martinez, Antonio
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1888
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA
    Fiorino, G.
    Ametzazurra, A.
    Nagore, D.
    Hernandez, A. M.
    Torres, N.
    Radice, S.
    Gilardi, D.
    Correale, C.
    Allocca, M.
    Furfaro, F.
    Alfieri, M.
    Pascual, J.
    Recalde, X.
    Martinez, A.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S388 - S388
  • [2] RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH THE REFERENCE INFLIXIMAB OR CT-P13 IN ROUTINE CLINICAL PRACTICE
    Ametzazurra, Amagoia
    Rivera, Natalia
    Hernandez, Alba Maria
    Arreba, Maria Paz
    Ruiz, Mara Esther
    Ortiz, Jone
    Munoz, Maria del Carmen
    Torres, Nerea
    Pascual, Javier
    Martinez, Antonio
    Allande, Mara Jesus
    Nagore, Daniel
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S391 - S391
  • [3] Rapid point-of-care monitoring of anti-infliximab antibodies in patients with inflammatory bowel disease treated with the reference infliximab or CT-P13 in routine clinical practice
    Ametzazurra, A.
    Rivera, N.
    Hernandez, A. M.
    Arreba, M. P.
    Ruiz, E.
    Ortiz, J.
    Munoz, M. D. C.
    Torres, N.
    Pascual, J.
    Martinez, A.
    Allande, M. J.
    Nagore, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S335 - S336
  • [4] Point of Care detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the biosimilar SB2: performance comparison with ELISA
    Atreya, R.
    Schmitt, H.
    Fischer, S.
    Neurath, M. F.
    Rekalde, X.
    Nagore, D.
    Ametzazurra, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S391 - S391
  • [5] Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease
    Fiorino, G.
    Ruiz-Aguello, M. B.
    Maguregui, A.
    Nagore, D.
    Radice, S.
    Gilardi, D.
    Correale, C.
    Allocca, M.
    Furfaro, F.
    Alfieri, M.
    Martinez, A.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S403 - S404
  • [6] ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE
    Fiorino, Gionata
    Ruiz-Arguello, Begona
    Maguregui, Ainara
    Nagore, Daniel
    Radice, Simona
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Furfaro, Federica
    Alfieri, Marina F.
    Maritnez, Antonio
    Danese, Silvio
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S386 - S386
  • [7] Infliximab biosimilar CT-P13 for inflammatory bowel disease
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 373 - 375
  • [8] Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
    Yuksel, I.
    Baspinar, B.
    Durak, M. B.
    Kilic, V.
    Kivrakoglu, F.
    Guven, I. E.
    Kosar, K.
    Erdogan, C.
    Alkan, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I487 - I487
  • [9] Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
    Yuksel, I.
    Baspinar, B.
    Durak, M. B.
    Kilic, V.
    Kivrakoglu, F.
    Guven, I. E.
    Kosar, K.
    Erdogan, C.
    Alkan, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I487 - I487
  • [10] CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease
    Albshesh, Ahmad
    Ben-Horin, Shomron
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 971 - 978
12345